
Join to View Full Profile
11100 Euclid AveCleveland, OH 44106
Phone+1 216-844-3657
Dr. Abada is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Warren Alpert Medical School of Brown University/ Women and Infants Hospital of Rhode IslandFellowship, 2022 - 2023
- Detroit Medical Center/Wayne State UniversityResidency, Pathology-Anatomic and Clinical, 2018 - 2022
- Brandeis UniversityMS Degree, International Health Policy and Management, 2010 - 2011
- University of Benin Faculty of MedicineClass of 2008
Certifications & Licensure
- MI State Medical License 2018 - 2027
- OH State Medical License 2023 - 2027
- RI State Medical License 2022 - 2023
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
Publications & Presentations
PubMed
- 3 citationsAnalysis of Concordance Between Next-Generation Sequencing Assessment of Microsatellite Instability and Immunohistochemistry-Mismatch Repair From Solid Tumors.Rouba Ali-Fehmi, Harris Benjamin Krause, Robert T Morris, John J Wallbillich, Logan Corey
JCO Precision Oncology. 2024-10-01 - 3 citationsHuman epidermal growth factor receptor-2 (HER2) expression in FIGO3 high-grade endometrial endometrioid carcinoma: Clinicopathologic characteristics and future directi...Evi Abada, Seongho Kim, Hyejeong Jang, Mira Kheil, Kamaljeet Singh
Gynecologic Oncology. 2024-06-01 - 2 citationsLow-level expression of human Epidermal growth Factor Receptor-2 (HER2) in High-Grade Mullerian Tumors: Implications for therapy decision making.Evi Abada, Kamaljeet Singh, Katrine Hansen, M Ruhul Quddus
Gynecologic Oncology Reports. 2023-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: